Diagnostic Value of Homocysteine Metabolic Pathway in Coronary Atherosclerosis: A Study on Reference Intervals and

Shen Li1, Furong Zhao2, Mo Hong3,4

  • 1Central Laboratory, Central Hospital of Dalian University of Technology, Dalian, People's Republic of China.

Insights

Establishing reference intervals for homocysteine (Hcy), cysteine (Cys), and methionine (Met) aids in coronary atherosclerosis (CA) risk assessment. These metabolites are independent risk factors, improving CA diagnosis and prediction accuracy.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Clinical Chemistry

Background:

  • Coronary atherosclerosis (CA) risk assessment requires accurate diagnostic tools.
  • The homocysteine (Hcy) metabolic pathway, including cysteine (Cys) and methionine (Met), is implicated in cardiovascular health.
  • Establishing reliable reference intervals for these metabolites is crucial for clinical application.

Purpose of the Study:

  • To determine reference intervals for the homocysteine (Hcy) metabolic pathway in healthy adults.
  • To explore the correlations between Hcy, Cys, and Met levels and coronary atherosclerosis (CA).
  • To enhance the risk assessment and diagnostic accuracy of CA using Hcy metabolic pathway markers.

Main Methods:

  • Direct continuous sampling was used to recruit 426 healthy adults for reference interval determination.
  • Serum levels of Hcy, Cys, and Met were analyzed using LC-MS/MS.
  • 75 patients diagnosed with CA were included to assess correlations with metabolite levels.

Main Results:

  • Reference intervals were established: Hcy 7-25 μmol/L, Cys 227-410 μmol/L, and Met 21-39 μmol/L.
  • Significant differences in Met and Hcy levels were observed between sexes but did not meet criteria for separate reference intervals.
  • Hcy, Cys, and Met were identified as independent risk factors for CA, with a combined AUC of 0.86, sensitivity of 78%, and specificity of 83%.

Conclusions:

  • The Hcy metabolic pathway provides valuable reference values for CA diagnosis and risk prediction.
  • Utilizing Hcy, Cys, and Met levels significantly enhances the capability for CA risk assessment.
  • This pathway offers a promising approach to improve diagnostic accuracy for coronary atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
377
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200